Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 28, 2019Journal of Clinical OncologyOpen Access

Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

YCYun ChenJYJinjun YeZZZhengfei Zhu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2019) studied this question.

synapsesocial.com/papers/69dc2fa48bac30e30e9f53f2https://doi.org/10.1200/jco.18.02122
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase II Randomized Trial of Two Nonoperative Regimens of Induction Chemotherapy Followed by Chemoradiation in Patients With Localized Carcinoma of the Esophagus: RTOG 01132008 · 125 citations
  2. 2Preoperative Therapy with Concurrent Paclitaxel/Carboplatin/Infusional 5-FU and Radiation Therapy in Locoregional Esophageal Cancer2003 · 104 citations
  3. 3A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma2017 · 8 citations
  4. 4Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations2017 · 132 citations
  5. 5Global cancer statistics, 20122015 · 27,466 citations